Late Breaking Science VI: New Frontiers in Lipid Therapy

Nov 18, 2019 9:00am ‐ Nov 18, 2019 10:15am

Credits: None available.

Standard: $35.00
Members: $25.00

Social Media Moderator - Mora
09:00am - 10:15am
Samia Mora

Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides (200-499mg/dl) on Statin Therapy (EVAPORATE Study)
09:00am - 10:15am
Matthew Budoff

Discussant - Nicholls
09:00am - 10:15am
Stephen Nicholls

Leveraging Genomic Discovery for Novel Therapeutics
09:00am - 10:15am
Daniel Rader

Safety and Efficacy of Inclisiran in Patients With Heterozygous Familial Hypercholesterolemia - Results From the Phase 3 ORION-9 Trial
09:00am - 10:15am
Frederick Raal

RNA Interference Targeting Apolipoprotein C-III Results in Deep and Prolonged Reductions in Plasma Triglycerides
09:00am - 10:15am
Christian Schwabe

RNA Interference Targeting Hepatic Angiopoietin-Like Protein 3 Results in Prolonged Reductions in Plasma Triglycerides and LDL-C in Human Subjects
09:00am - 10:15am
Gerald Watts

Discussant: What We Learned
09:00am - 10:15am
Daniel Rader

Benefit of a Target LDL Cholesterol Less Than 70 mg/dl After an Ischemic Stroke of Atherosclerotic Origin, the Treat Stroke to Target Trial Results
09:00am - 10:15am
Pierre Amarenco

Late Breaking Science VI: New Frontiers in Lipid Therapy - Q&A
09:00am - 10:15am
AHA Discussant

Credits: None available.

You must be logged in and own this session in order to post comments.